New Zealand patent office approves Dicot patent for libiguin synthesis

Uppsala, Sweden, 3 November 2016

The New Zealand patent office today told that Dicot patent "Novel compounds, their manufacture and use in synthesis" covering the chemical synthesis of the libiguins has been granted in New Zealand.

The approval of this patent, which part of a family of patents covering the synthesis of the libiguins, is an important step for a broad world coverage for Dicot's protection of the libiguins, says Dicot CEO Jarl Wikberg.